2021

1. Deep sequencing of prostaglandin-endoperoxide synthase (PTGE) genes reveals genetic susceptibility for cross-reactive hypersensitivity to NSAID

   British Journal of Pharmacology, Vol. 178, Núm. 5, pp. 1218-1233

2. Lack of Major Involvement of Common CYP2C Gene Polymorphisms in the Risk of Developing Cross-Hypersensitivity to NSAIDs

   Frontiers in Pharmacology, Vol. 12